Fortress Biotech Inc (FBIO): Next-Year EPS Estimate 28.57%
As of 2026-05-18, Fortress Biotech Inc (FBIO) has a next-year EPS growth estimate of 28.57%.
On 2026-04-22, analyst consensus for FBIO's next-year EPS growth shifted from 1362.50% to 28.57% — a negative change of 1333.93 percentage points. The revised estimate has been sustained across 20 subsequent trading sessions. Current-year growth is projected at -900.00%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 28.57%
- EPS growth this year
- -900.00%
- EPS next quarter (est)
- -$0.19
- Last price
- $2.55
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-18 | 28.57% | -900.00% | -$0.19 | $2.55 |
| 2026-05-17 | 28.57% | -900.00% | -$0.19 | $2.41 |
| 2026-05-14 | 28.57% | -900.00% | -$0.22 | $2.30 |
| 2026-05-13 | 28.57% | -900.00% | -$0.22 | $2.21 |
| 2026-05-12 | 28.57% | -900.00% | -$0.22 | $2.26 |
| 2026-05-11 | 28.57% | -900.00% | -$0.22 | $2.24 |
| 2026-05-10 | 28.57% | -900.00% | -$0.22 | $2.39 |
| 2026-05-07 | 28.57% | -900.00% | -$0.22 | $2.40 |
| 2026-05-06 | 28.57% | -900.00% | -$0.22 | $2.55 |
| 2026-05-05 | 28.57% | -900.00% | -$0.22 | $2.46 |
| 2026-05-04 | 28.57% | -900.00% | -$0.22 | $2.38 |
| 2026-05-03 | 28.57% | -900.00% | -$0.22 | $2.33 |
| 2026-04-30 | 28.57% | -900.00% | -$0.22 | $2.30 |
| 2026-04-29 | 28.57% | -900.00% | -$0.22 | $2.22 |
| 2026-04-28 | 28.57% | -900.00% | -$0.22 | $2.24 |
| 2026-04-27 | 28.57% | -900.00% | -$0.22 | $2.27 |
| 2026-04-26 | 28.57% | -900.00% | -$0.22 | $2.33 |
| 2026-04-24 | 28.57% | -900.00% | -$0.22 | $2.33 |
| 2026-04-23 | 28.57% | -900.00% | -$0.22 | $2.23 |
| 2026-04-22 | 28.57% | -900.00% | -$0.22 | $2.25 |
| 2026-04-21 | 1362.50% | 42.86% | -$0.22 | $2.23 |
| 2026-04-20 | 1362.50% | 42.86% | -$0.22 | $2.32 |
| 2026-04-19 | 1362.50% | 42.86% | -$0.22 | $2.36 |
| 2026-04-16 | 1362.50% | 42.86% | -$0.22 | $2.35 |
| 2026-04-15 | 1362.50% | 42.86% | -$0.22 | $2.43 |
| 2026-04-14 | 1362.50% | 42.86% | -$0.22 | $2.42 |
| 2026-04-13 | 1362.50% | 42.86% | -$0.22 | $2.42 |
| 2026-04-12 | 1362.50% | 42.86% | -$0.22 | $2.35 |
| 2026-04-10 | 1362.50% | 42.86% | -$0.22 | $2.35 |
| 2026-04-09 | 1362.50% | 42.86% | -$0.22 | $2.40 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Fortress Biotech Inc's next-year EPS growth estimate?▾
As of 2026-05-18, Fortress Biotech Inc (FBIO) has a next-year EPS growth estimate of 28.57%, based on analyst consensus.
When was the latest EPS estimate revision for FBIO?▾
The most recent revision occurred on 2026-04-22, when analysts adjusted the next-year EPS growth estimate from 1362.50% to 28.57%.
What sector and industry does Fortress Biotech Inc belong to?▾
Fortress Biotech Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. FBIO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Fortress Biotech Inc (FBIO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports